Pay in 4 interest-free payments of $7.36 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
The type 2 diabetes mellitus segment captured the largest market share in 2023 and is anticipated to exhibit significant growth through 2032
This formulation reflects a patient-centered approach to comprehensive metabolic health
Increases mobility for people with peripheral artery disease Peripheral artery disease occurs when the peripheral arteries become clogged by plaque
Patients inject once daily, before sleep, at least 2 hours after their last meal
The optimal dosing schedule will vary depending on the desired therapeutic outcome and size of the subject
Funding National Council for Scientific and Technological Development (CNPq, MCTI, Brazil) grant number 406484/2022-8 (INCT BioOncoPed), grant number 400120/2023-2, CNPq MAI/DAI and Centro de Diagnsticos Antomo-Patolgicos CEDAP
